<interlocking directorships and such>
(if you've followed my icor rants)
Aurora Funds:
Doug Gooding
Venture Partner
Doug serves as President at Regado Biosciences, one of
Aurora’s portfolio companies. As a Venture Partner for
Aurora, he works primarily with Aurora's life science
portfolio, specifically in the areas of biotechnology, drug
discovery and development. Doug serves on the Board of
Directors of TissueInformatics, Metabolon
and Cropsolution.
Prior to joining Aurora in 2001, he was a Director of
Business Development at Paradigm Genetics (PDGM).
Doug also spent four years at Incyte Pharmaceuticals (INCY),
where he was the manager of the cDNA Library Construction
Group. In addition, he worked as a Research Associate at
Stratagene Cloning Systems in La Jolla, California.
Doug received a Bachelor of Arts in Biology, with a minor in
Chemistry, from the University of San Diego and a MBA from
the Kenan-Flagler Business School in Chapel Hill, NC.
aurorafunds.com
..................
Icoria (formerly Paradigm Genetics) acquired Aurora portfolio company, TissueInformatics in March 2004 |
